Evidence map›Paper›PMID 20084543›Full record

ArticleCancer causes & control : CCC2010

Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Jaymie R Meliker, Melissa J Slotnick, Gillian A AvRuskin, David Schottenfeld, Geoffrey M Jacquez, Mark L Wilson, Pierre Goovaerts, Alfred Franzblau, Jerome O Nriagu

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 5 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 5 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Ambient UVR and Environmental Arsenic Exposure in Relation to Cutaneous Melanoma in Iowa.International journal of environmental research and public health · 2022
    Article
  16. Article
  17. Toxic Metal Implications on Agricultural Soils, Plants, Animals, Aquatic life and Human Health.International journal of environmental research and public health · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jaymie R MelikerGraduate Program in Public Health, Department of Preventive Medicine, Stony Brook University Medical Center, Stony Brook, NY 11794-8338, USA. jrmeliker@gmail.com
Melissa J Slotnick
Gillian A AvRuskin
David Schottenfeld
Geoffrey M Jacquez
Mark L Wilson
Pierre Goovaerts
Alfred Franzblau
Jerome O Nriagu
University of Michigan–Ann Arbor · USBiomedware (United States) · USStony Brook University Hospital · US

Funding

Arsenic Exposure and Bladder Cancer in MichiganR01CA096002 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NRIAGU, JEROME · 2002 to 2006
$2.3M
NCI NIH HHS R01 CA096002NCI NIH HHS R01 CA96002-10
6 · The paper itself

Abstract

objectiveArsenic in drinking water has been linked with the risk of urinary bladder cancer, but the dose-response relationships for arsenic exposures below 100 microg/L remain equivocal. We conducted a population-based case-control study in southeastern Michigan, USA, where approximately 230,000 people were exposed to arsenic concentrations between 10 and 100 microg/L.

methodsThis study included 411 bladder cancer cases diagnosed between 2000 and 2004, and 566 controls recruited during the same period. Individual lifetime exposure profiles were reconstructed, and residential water source histories, water consumption practices, and water arsenic measurements or modeled estimates were determined at all residences. Arsenic exposure was estimated for 99% of participants' person-years.

resultsOverall, an increase in bladder cancer risk was not found for time-weighted average lifetime arsenic exposure >10 microg/L when compared with a reference group exposed to <1 microg/L (odds ratio (OR) = 1.10; 95% confidence interval (CI): 0.65, 1.86). Among ever-smokers, risks from arsenic exposure >10 microg/L were similarly not elevated when compared to the reference group (OR = 0.94; 95% CI: 0.50, 1.78).

conclusionsWe did not find persuasive evidence of an association between low-level arsenic exposure and bladder cancer. Selecting the appropriate exposure metric needs to be thoughtfully considered when investigating risk from low-level arsenic exposure.

Indexed as

AdultAgedAge FactorsArsenicCase-Control StudiesDose-Response Relationship, DrugEnvironmental ExposureFemaleHumansIncidenceMaleMichiganMiddle AgedOdds RatioRisk FactorsSex DistributionArsenic

Identifiers

PMID20084543
PMCPMC3962589
OpenAlexW2080379480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.